Looking for 107753-78-6 / Zafirlukast API manufacturers, exporters & distributors?
Zafirlukast manufacturers, exporters & distributors
1
49
PharmaCompass offers a list of Zafirlukast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Zafirlukast manufacturer or Zafirlukast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zafirlukast manufacturer or Zafirlukast supplier.
API | Excipient name
Zafirlukast
Synonyms
107753-78-6, Accolate, Olmoran, Ici-204219, Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1h-indol-5-yl)carbamate, Accoleit
Unique Ingredient Identifier (UNII)
XZ629S5L50
About Zafirlukast
Zafirlukast is a tolyl compound and leukotriene receptor antagonist (LTRA), with anti-asthmatic and potential capsular contracture-preventing activities. Upon administration, zafirlukast selectively and competitively binds to and blocks the cysteinyl leukotriene 1 receptor (CYSLTR1), thereby preventing the potent pro-inflammatory mediators leukotriene C4, D4 and E4 from binding. This prevents leukotriene-mediated actions, including enhanced migration of eosinophils and neutrophils, increased adhesion of leukocytes, increased monocyte and neutrophil aggregation, increased airway edema, inflammation, capillary permeability and bronchoconstriction. In addition, zafirlukast may decrease collagen deposition, fibrosis, and capsular thickness after implantation, thereby preventing scar tissue.